Dr. Robert Debernardo
Gynecologic Oncologist
Cleveland Clinic
Cleveland, OH 44197
Dena Svoboda, 56, never expected a bad case of acid reflux would turn out to be cancer. “I thought it was a gallbladder issue, but it wasn’t,” said Dena, of Sagamore Hills, Ohio. “It ended up being a 25-pound tumor.”
For colleagues who’ve never performed or observed the procedure, Dr. Robert DeBernardo of Cleveland Clinic describes what happens during hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer patients.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, discusses recent findings about hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer that were presented in the NEJM and at ASCO.
How should we interpret recent findings about the possible role of the fallopian tubes in ovarian cancer? Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, gives us his take.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, describes these aspects of HIPEC in patients with ovarian cancer.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, addresses some of the questions surrounding HIPEC treatment for ovarian cancer
Fill out my online form.
Dr. Robert Debernardo
Have some Questions?
The contact form located on this page is the best way to get in touch with Dr. Robert Debernardo concerning a personalized HIPEC conversation. The surgeon or their office will make every effort to contact you as soon as possible.
To have a conversation about the HIPEC procedure you do not need a referral from a doctor. There is no charge for an initial conversation.
View Contact Information
Phone: 216 444-7645
Dena Svoboda, 56, never expected a bad case of acid reflux would turn out to be cancer. “I thought it was a gallbladder issue, but it wasn’t,” said Dena, of Sagamore Hills, Ohio. “It ended up being a 25-pound tumor.”
For colleagues who’ve never performed or observed the procedure, Dr. Robert DeBernardo of Cleveland Clinic describes what happens during hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer patients.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, discusses recent findings about hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer that were presented in the NEJM and at ASCO.
How should we interpret recent findings about the possible role of the fallopian tubes in ovarian cancer? Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, gives us his take.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, describes these aspects of HIPEC in patients with ovarian cancer.
Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, addresses some of the questions surrounding HIPEC treatment for ovarian cancer